Masatoshi Haruta

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Vascular Endothelial Growth Factor

Optical Coherence Tomography

Age Related Macular Degeneration

Top Venues

Clinical ophthalmology (Auckland, N.Z.)

Therapeutic advances in ophthalmology

Acta ophthalmologica

This page only lists publications with an associated author ORCID identifier.

Publications

Nobuhiro Kato, Masatoshi Haruta, Kei Furushima, Rikki Arai, Yu Matsuo, Shigeo Yoshida
Decrease in Ocular Blood Flow Thirty Minutes After Intravitreal Injections of Brolucizumab and Aflibercept for Neovascular Age-Related Macular Degeneration. Clinical ophthalmology (Auckland, N.Z.) 17 (2023)
Nobuhiro Kato, Masatoshi Haruta, Kei Furushima, Rikki Arai, Yu Matsuo, Shigeo Yoshida
Decrease in Ocular Blood Flow Thirty Minutes After Intravitreal Injections of Brolucizumab and Aflibercept for Neovascular Age-Related Macular Degeneration. Clinical ophthalmology (Auckland, N.Z.) 17 (2023)
Nobuhiro Kato, Masatoshi Haruta, Kei Furushima, Rikki Arai, Yu Matsuo, Shigeo Yoshida
Decrease in Ocular Blood Flow Thirty Minutes After Intravitreal Injections of Brolucizumab and Aflibercept for Neovascular Age-Related Macular Degeneration. Clinical ophthalmology (Auckland, N.Z.) 17 (2023)
Nobuhiro Kato, Masatoshi Haruta, Kei Furushima, Rikki Arai, Yu Matsuo, Shigeo Yoshida
Decrease in Ocular Blood Flow Thirty Minutes After Intravitreal Injections of Brolucizumab and Aflibercept for Neovascular Age-Related Macular Degeneration. Clinical ophthalmology (Auckland, N.Z.) 17 (2023)
Junichi Itou, Kei Furushima, Masatoshi Haruta, Nobuhiro Kato, Rikki Arai, Kenichiro Mori, Keijiro Ishikawa, Shigeo Yoshida
Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema. Clinical ophthalmology (Auckland, N.Z.) 17 (2023)
Junichi Itou, Kei Furushima, Masatoshi Haruta, Nobuhiro Kato, Rikki Arai, Kenichiro Mori, Keijiro Ishikawa, Shigeo Yoshida
Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema. Clinical ophthalmology (Auckland, N.Z.) 17 (2023)
Koki Ishibashi, Hiroyuki Yatsuka, Masatoshi Haruta, Kenichi Kimoto, Shigeo Yoshida, Toshiaki Kubota
Branch Retinal Artery Occlusions, Paracentral Acute Middle Maculopathy and Acute Macular Neuroretinopathy After COVID-19 Vaccinations. Clinical ophthalmology (Auckland, N.Z.) 16 (2022)
Yu Matsuo, Masatoshi Haruta, Yumi Ishibashi, Koki Ishibashi, Kei Furushima, Nobuhiro Kato, Kenta Murotani, Shigeo Yoshida
Visual Outcomes and Prognostic Factors of Large Submacular Hemorrhages Secondary to Polypoidal Choroidal Vasculopathy. Clinical ophthalmology (Auckland, N.Z.) 15 (2021)
Koki Ishibashi, Masatoshi Haruta, Yumi Ishibashi, Rie Noda, Shotaro Dake, Shigeo Yoshida
Four-year outcomes of intravitreal aflibercept treatment for neovascular age-related macular degeneration using a treat-and-extend regimen in Japanese patients. Therapeutic advances in ophthalmology 13 (2021)
Masatoshi Haruta, Koki Ishibashi, Yumi Ishibashi, Shotaro Dake, Kensuke Sasaki, Rie Noda, Yumiko Yoshida, Shigeo Yoshida
Multiple retinal vein thromboses after intravitreal aflibercept injections for age-related macular degeneration. Acta ophthalmologica 98 (4) (2020)